Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Finished Goods: 2015-2016

  • Cumberland Pharmaceuticals' Finished Goods rose 56.64% to $2.3 million in Q4 2016 from the same period last year, while for Dec 2016 it was $2.3 million, marking a year-over-year increase of 56.64%. This contributed to the annual value of $2.3 million for FY2016, which is 56.64% up from last year.
  • Cumberland Pharmaceuticals' Finished Goods amounted to $2.3 million in Q4 2016, which was up 56.64% from $1.5 million recorded in Q4 2015.
  • Cumberland Pharmaceuticals' 5-year Finished Goods high stood at $2.3 million for Q4 2016, and its period low was $1.5 million during Q4 2015.
  • For the 2-year period, Cumberland Pharmaceuticals' Finished Goods averaged around $1.9 million, with its median value being $1.9 million (2015).
  • Data for Cumberland Pharmaceuticals' Finished Goods shows a peak YoY surged of 56.64% (in 2016) over the last 5 years.
  • Over the past 2 years, Cumberland Pharmaceuticals' Finished Goods (Quarterly) stood at $1.5 million in 2015, then soared by 56.64% to $2.3 million in 2016.